Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
publish chart | backtests Type: candle | line | advanced    Timeframe: intraday | daily | weekly | monthly
CRL [NYSE]
Charles River Laboratories International, Inc.
Healthcare | Biotechnology | USA
financial highlights | statements
Index- P/E20.16 EPS (ttm)2.09 Insider Own1.90% Shs Outstand47.66M Perf Week0.00%
Market Cap2.01B Forward P/E13.74 EPS next Y3.07 Insider Trans-0.66% Shs Float48.90M Perf Month-6.17%
Income100.90M PEG2.53 EPS next Q0.71 Inst Own96.00% Short Float1.41% Perf Quarter-5.85%
Sales1.13B P/S1.77 EPS this Y-6.30% Inst Trans2.69% Short Ratio1.42 Perf Half Y13.28%
Book/sh13.18 P/B3.20 EPS next Y8.72% ROA6.10% Target Price44.82 Perf Year31.48%
Cash/sh2.25 P/C18.73 EPS next 5Y7.97% ROE16.10% 52W Range31.48 - 46.90 Perf YTD12.46%
Dividend- P/FCF11.62 EPS past 5Y-1.30% ROI10.90% 52W High-10.15% Beta1.21
Dividend %- Quick Ratio1.20 Sales past 5Y-1.70% Gross Margin34.60% 52W Low33.86% ATR0.84
Employees7200 Current Ratio1.50 Sales Q/Q1.80% Oper. Margin16.20% RSI (14)42.94 Volatility1.63% 1.92%
OptionableYes Debt/Eq1.03 EPS Q/Q-1.90% Profit Margin8.50% Rel Volume0.54 Prev Close42.56
ShortableYes LT Debt/Eq0.82 EarningsMay 01 AMC Payout0.00% Avg Volume484.41K Price42.14
Recom2.80 SMA20-2.14% SMA50-2.30% SMA2003.12% Volume259,871 Change-0.99%
03-Jun-13Reiterated Barclays Equal Weight $38 → $41
02-May-13Reiterated ISI Group Neutral $45.50 → $44.50
14-Feb-13Reiterated ISI Group Neutral $40.50 → $43
14-Jul-11Initiated BB&T Capital Mkts Buy $47
05-May-11Reiterated UBS Neutral $40 → $42
06-Jan-11Downgrade Deutsche Bank Buy → Hold $37 → $37
12-May-10Upgrade Robert W. Baird Neutral → Outperform $37
07-Jan-10Upgrade Deutsche Bank Hold → Buy $38.50 → $39
09-Nov-09Downgrade Barclays Capital Overweight → Equal Weight
13-May-09Initiated Deutsche Securities Hold
20-Apr-09Downgrade Jefferies & Co Buy → Hold $33
11-Feb-09Reiterated Jefferies & Co Buy $31 → $33
05-Feb-09Reiterated Barclays Capital Overweight $42 → $38
30-Jan-09Downgrade UBS Neutral → Sell
26-Jan-09Reiterated Jefferies & Co Buy $35 → $31
20-Jan-09Reiterated Barclays Capital Overweight $44 → $42
20-Nov-08Reiterated UBS Neutral $30 → $22
10-Nov-08Reiterated UBS Neutral $39 → $30
20-Aug-08Initiated UBS Neutral $71
20-Aug-08Initiated UBS Neutral $104
18-Jun-13 01:34PM  Goldman Sachs downgrades Charles River Labs AP
09:25AM  Stock Downgrades: Charles River Laboratories Up a Creek at Minyanville
08:37AM  Analysts' Actions: CRL CVLT LNKD Q WETF TheStreet
03-Jun-13 04:15PM  Charles River Laboratories to Present at June Investor Conferences Business Wire
31-May-13 09:53AM  [video] Cramer's Six in 60: Guess, Disney & More at CNBC
07:57AM  Charles River Labs downgraded at Raymond James theflyonthewall.com
29-May-13 06:14AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obli EDGAR Online
15-May-13 01:04PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Financials EDGAR Online Financials
14-May-13 07:01AM  Cramer's Mad Money - 3 Things Driving The Market Higher (5/13/13) at Seeking Alpha
13-May-13 06:15PM  [video] What's Working in Pharma at CNBC
05:58PM  The Danger of Chasing This IPO's Profits at Motley Fool
10-May-13 08:13AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
09-May-13 11:13AM  Pharmaceutical services provider Quintiles surges on first day of trading at theflyonthewall.com
08-May-13 06:45AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report EDGAR Online
06-May-13 04:30PM  Charles River Laboratories to Present at Bairds Growth Stock Conference Business Wire
04-May-13 04:43PM  3 Healthcare Stock Winners and 1 Loser Post Earnings at Wall St. Cheat Sheet
03-May-13 06:58PM  [video] No Huddle Offense: What's Working In Pharma at CNBC
07:10AM  Cramer's Mad Money - The Most Important Game Changer For 2013 (5/2/13) at Seeking Alpha
06:00AM  Cramer's Top Stock Picks: AGN BP CRL PRU AIG at TheStreet
02-May-13 08:11PM  Cramer's 'Mad Money' Recap: A New Dawn for Europe? at TheStreet
07:10PM  Charles River Laboratories International Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
06:45PM  [video] Charles River CEO: Had a Negligible Impact From Sequester at CNBC
01:00PM  Charles River Misses Estimates in 1Q Zacks
08:00AM  Charles River Laboratories International, Inc. Earnings Call scheduled for 8:00 am ET today CCBN
01-May-13 11:06PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan EDGAR Online
06:10PM  Charles River Laboratories International Earnings: Everything You Must Know Now at Wall St. Cheat Sheet
04:54PM  InPlay: Charles River misses by $0.02, misses on revs; guides FY13 EPS in-line, revs above consensus Briefing.com
04:30PM  Charles River Laboratories Announces First-Quarter 2013 Results from Continuing Operations Business Wire
12:10PM  Charles River Laboratories International Earnings Preview: Can This Streak Continue? at Wall St. Cheat Sheet
07:07AM  Q1 2013 Charles River Laboratories International, Inc. Earnings Release - After Market Close CCBN
29-Apr-13 11:19AM  Unmet Medical Need in the Hepatitis C Space Creates Opportunities for Pharmaceutical and Biotech Companies: Disease Has High Number of Patients and Needs Curative Therapy with High Rate of Efficacy Wall Street Transcript
17-Apr-13 02:43PM  The Healthy Play In Contract Research Organizations at Investopedia
08-Apr-13 04:30PM  Charles River Laboratories Schedules First-Quarter 2013 Earnings Release and Conference Call Business Wire
05-Apr-13 04:58PM  Charles River Laboratories International Larger Than S&P 500 Component Apollo Group at Forbes
03-Apr-13 05:40PM  Cramer's 6 Stocks in 60 Seconds: CRL TUMI DLTR LM PNRA VLO (Update1) at TheStreet
03:27PM  Analyst Moves: CI, CRL at Forbes
11:39AM  Cramer's 6 Stocks in 60 Seconds: CRL TUMI DLTR LM PNRA VLO at TheStreet
11:37AM  Analyst cuts Charles River Labs rating, target AP
07:08AM  Ahead of the Bell: Charles River Laboratories AP
27-Mar-13 05:00PM  Analyst Moves: CRL, IR at Forbes
19-Mar-13 10:00AM  On The Fly: Analyst Initiation Summary theflyonthewall.com
18-Mar-13 10:06AM  On The Fly: Analyst Initiation Summary theflyonthewall.com
15-Mar-13 12:35PM  Parexel Stock Hits New High As Buyback Ramps Up at Investor's Business Daily
09:21AM  Stanley Black & Decker CEO Sells $12 Million in Shares and 4 Insider Sales to Note at Wall St. Cheat Sheet
08:05AM  [video] Expand Your Portfolio With These Alternative Plays at CNBC
13-Mar-13 12:00PM  Charles River Laboratories International, Inc. Presents at Barclays Global Healthcare Conference, Mar-13-2013 09:30 AM at Seeking Alpha
10-Mar-13 09:17PM  China government overhaul includes food and drug safety, WSJ says theflyonthewall.com
05-Mar-13 01:04PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Financials EDGAR Online Financials
04-Mar-13 03:45AM  Call buying flows in Charles River optionMONSTER
01-Mar-13 09:00AM  Charles River Laboratories to Present at March Investor Conferences Business Wire
27-Feb-13 04:07PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 10-K, Annual Report EDGAR Online
20-Feb-13 10:31AM  On The Fly: Analyst Upgrade Summary theflyonthewall.com
19-Feb-13 10:11AM  On The Fly: Analyst Upgrade Summary theflyonthewall.com
15-Feb-13 02:17PM  Charles River Labs pleases analysts, despite sales slip in 2012 at bizjournals.com
14-Feb-13 03:15PM  Charles River Laboratories CEO discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha
02:56PM  Mixed 4Q for Charles River Zacks
01:04PM  Charles River Laboratories International Beats on EPS But GAAP Results Lag at Motley Fool
09:17AM  New Star Analyst Rankings for Charles River Laboratories Inte StarMine
08:30AM  Charles River Laboratories International, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
07:38AM  Charles River Laboratories International, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
06:09AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan EDGAR Online
13-Feb-13 04:37PM  InPlay: Charles River beats by $0.04, reports revs in-line; reaffirms FY13 EPS guidance, raises FY13 rev on rediced FX headwind Briefing.com
04:30PM  Charles River Laboratories Announces Fourth-Quarter and Full-Year 2012 Results from Continuing Operations Business Wire
07:07AM  Q4 2012 Charles River Laboratories International, Inc. Earnings Release - After Market Close CCBN
01:08AM  What to Expect from Charles River Laboratories International at Motley Fool
03-Feb-13 11:14AM  Do You Own This $2 Billion Hedge Funds Best Stock Picks? at Motley Fool
22-Jan-13 08:48PM  Billion Dollar Manager David Dremans Biggest Holdings at Motley Fool
09:00AM  Charles River Laboratories Schedules Fourth-Quarter and Full-Year 2012 Earnings Release and Conference Call Business Wire
18-Jan-13 12:12PM  Life for Sale at Forbes
09:02AM  Don't Get Too Worked Up Over Charles River Laboratories International's Latest Numbers at Motley Fool
17-Jan-13 10:51AM  CBS Value Enhanced by REIT and 4 Stock Analyses to Track at Wall St. Cheat Sheet
10-Jan-13 07:30PM  10 Biotech Stocks With A History Of Beating Earning Expectations at TheStreet
09:06AM  Cramer: Sell BankUnited and Buy Acorda, Charles River Labs and These 2 Sizzling Stocks at Wall St. Cheat Sheet
06:00AM  Cramer's Top Stock Picks: UTX ACOR CRL AA at TheStreet
09-Jan-13 07:50PM  Cramer's 'Mad Money' Recap: Bright Spots at TheStreet
06:28PM  Biopharma Play That May Bypass FDA Roulette at CNBC
06:25PM  [video] Charles River Laboratories CEO on Drug Development at CNBC
06:00PM  [video] Mad Money, January 9, 2013 at CNBC
08-Jan-13 04:28PM  Charles River Acquires Vital River Zacks
09:42AM  Charles River Labs sees Vital River slightly accretive to EPS in 2013 theflyonthewall.com
09:37AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and E EDGAR Online
07-Jan-13 05:01PM  InPlay: Charles River completes acquisition of majority ownership of Vital River: expected to add more than 1% to 2013 total net sales and be slightly accretive to 2013 EPS Briefing.com
05:00PM  Charles River Laboratories Completes Acquisition of Majority Ownership of Vital River Business Wire
08:30AM  Charles River Laboratories to Present at J.P. Morgan Healthcare Conference Business Wire
03-Jan-13 04:54PM  Charles River Laboratories International Larger Than S&P 500 Component Advanced Micro Devices at Forbes
08:38AM  BASi Introduces Culex NxT Zacks
31-Dec-12 03:00PM  [$$] Contract Research Could Expand at Barrons.com
08:57AM  Strengthening Moats Mean Improving Returns For CRO Investors at Seeking Alpha
07:00AM  Strengthening Moats Mean Improving Returns for CRO Investors Morningstar
28-Dec-12 01:12AM  How Should You Be Playing Charles River Laboratories International? at Motley Fool
25-Dec-12 07:00AM  These Stocks Are Gifts That Could Keep on Giving Morningstar
24-Dec-12 12:32PM  Vertex Pharmaceuticals and Other Healthcare Stocks Making Big Moves on December 24, 2012 at Investopedia
14-Dec-12 06:02PM  NYSE stocks posting largest percentage decreases AP
01:25PM  NYSE stocks posting largest percentage decreases AP
13-Dec-12 06:39PM  Charles River 2013 EPS Guidance Lags Zacks
03:32PM  Analyst Moves: CRL, DAL at Forbes
01:34PM  5 Stocks With Unusual Volume at Seeking Alpha
12:30PM  Regeneron Pharmaceuticals and More Big Movers in Healthcare on December 13, 2012 at Investopedia
10:05AM  Vertex Sees Lowered Estimates and 3 Must-See Stock Analyses at Wall St. Cheat Sheet
09:11AM  Here's How Charles River Laboratories International Is Making You So Much Cash at Motley Fool
Charles River Laboratories International, Inc., together with its subsidiaries, provides research models and associated services, and outsourced preclinical services to accelerate the drug discovery and development process. It operates in two segments, Research Models and Services (RMS), and Preclinical Services (PCS). The RMS segment is involved in the production and sale of research model strains, principally genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also offers a range of services to assist customers in the drug discovery and development process, which include genetically engineered models and services, insourcing solutions, discovery research services, research animal diagnostic services, endotoxin and microbial detection products and services, and avian vaccine products and services. The PCS segment provides preclinical services, including both in vivo and in vitro studies, supportive laboratory services, and strategic preclinical consulting and program management to support product development. This segment offers services in the areas of bioanalysis, pharmacokinetics, and drug metabolism; toxicology; and pathology services, as well as testing of biologics and devices frequently outsourced by pharmaceutical and biotechnology companies. The company serves pharmaceutical companies, biotechnology companies, government agencies, hospitals, and academic institutions worldwide. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ACKERMAN THOMAS FCorp. Executive VP & CFOJun 03Sale42.404,000169,610105,039Jun 05 09:59 AM
FOSTER JAMES CChairman, President and CEOMay 14Option Exercise38.03113,8104,328,194480,390May 16 01:53 PM
FOSTER JAMES CChairman, President and CEOMay 14Sale45.00113,8105,121,450366,580May 16 01:53 PM
MASSARO GEORGEDirectorMay 10Sale44.092,02089,06221,368May 13 12:40 PM
FOSTER JAMES CChairman, President and CEOMar 15Option Exercise33.06204,5486,762,657571,128Mar 19 05:08 PM
FOSTER JAMES CChairman, President and CEOMar 15Sale45.702,406109,954366,580Mar 19 05:25 PM
FOSTER JAMES CChairman, President and CEOMar 15Sale45.0820,054904,036368,986Mar 19 05:24 PM
FOSTER JAMES CChairman, President and CEOMar 15Sale44.7537,2131,665,358389,040Mar 19 05:21 PM
FOSTER JAMES CChairman, President and CEOMar 15Sale44.6652,7482,355,943426,253Mar 19 05:19 PM
FOSTER JAMES CChairman, President and CEOMar 15Sale44.5540,4861,803,740479,001Mar 19 05:16 PM
FOSTER JAMES CChairman, President and CEOMar 15Sale44.3728,8091,278,360519,487Mar 19 05:11 PM
FOSTER JAMES CChairman, President and CEOMar 15Sale44.6622,8321,019,757548,296Mar 19 05:08 PM
JOHST DAVID PCorp Executive VPMar 13Option Exercise24.8017,038422,542158,837Mar 14 04:04 PM
JOHST DAVID PCorp Executive VPMar 13Sale45.0017,038766,710141,799Mar 14 04:04 PM
JOHST DAVID PCorp Executive VPMar 08Option Exercise32.8726,600874,342168,399Mar 12 10:02 AM
GILLETT NANCYCorporate Executive VPMar 08Option Exercise37.9737,0371,406,13791,547Mar 12 10:26 AM
JOHST DAVID PCorp Executive VPMar 08Sale42.2526,6001,123,850141,799Mar 12 10:02 AM
GILLETT NANCYCorporate Executive VPMar 08Sale42.713,300140,95754,510Mar 12 10:27 AM
GILLETT NANCYCorporate Executive VPMar 08Sale42.6633,7371,439,21157,810Mar 12 10:26 AM
GILLETT NANCYCorporate Executive VPMar 07Option Exercise36.8018,412677,47872,922Mar 11 04:56 PM
GILLETT NANCYCorporate Executive VPMar 07Sale41.7218,412768,14654,510Mar 11 04:56 PM
GILLETT NANCYCorporate Executive VPMar 07Sale41.736,924288,91254,510Mar 11 04:51 PM
GILLETT NANCYCorporate Executive VPMar 05Option Exercise24.8014,813367,36276,247Mar 07 03:01 PM
GELLER JORGCorporate Executive VPMar 05Sale41.291,50061,93555,085Mar 06 10:04 AM
GILLETT NANCYCorporate Executive VPMar 05Sale41.1814,813610,06461,434Mar 07 03:01 PM
GELLER JORGCorporate Executive VPMar 01Option Exercise24.8012,825318,06069,410Mar 05 09:52 AM
GELLER JORGCorporate Executive VPMar 01Sale40.3912,825517,99456,585Mar 05 09:52 AM
GELLER JORGCorporate Executive VPFeb 28Sale40.7381233,07056,585Mar 04 09:21 AM
FOSTER JAMES CChairman, President and CEOFeb 27Option Exercise24.8053,3131,322,162419,893Mar 01 03:58 PM
GELLER JORGCorporate Executive VPFeb 27Sale39.8458123,14857,397Mar 01 10:14 AM
FOSTER JAMES CChairman, President and CEOFeb 27Sale40.0053,3132,132,520366,580Mar 01 03:58 PM
GELLER JORGCorporate Executive VPFeb 25Sale40.4443117,42957,978Feb 26 04:43 PM
GILLETT NANCYCorporate Executive VPFeb 20Sale41.7115,640652,32958,860Feb 22 10:01 AM
ACKERMAN THOMAS FCorp. Executive VP & CFOJan 04Option Exercise32.8726,600874,342139,487Jan 08 12:26 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOJan 04Sale39.0030,6001,193,400108,887Jan 08 12:26 PM
CHUBB STEPHEN DDirectorJan 02Sale37.901,00037,90031,603Jan 03 09:34 AM
WALTRIP WILLIAMDirectorDec 05Option Exercise29.3821,150621,36042,980Dec 06 10:30 AM
WALTRIP WILLIAMDirectorDec 05Sale38.823,901151,42121,830Dec 06 10:31 AM
WALTRIP WILLIAMDirectorDec 05Sale38.6317,249666,25225,731Dec 06 10:30 AM
WALTRIP WILLIAMDirectorNov 28Sale38.9050019,4520Nov 30 01:29 PM
WALTRIP WILLIAMDirectorNov 28Sale38.7414,273552,936500Nov 30 01:28 PM
GELLER JORGCorporate Executive VPOct 04Sale40.5389336,19052,255Oct 09 09:43 AM
FOSTER JAMES CChairman, President and CEOOct 01Option Exercise24.8053,3121,322,138427,207Oct 03 12:00 PM
FOSTER JAMES CChairman, President and CEOOct 01Sale40.0053,3122,132,480373,895Oct 03 12:00 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOOct 01Sale40.008,000320,000112,887Oct 03 11:57 AM
CHUBB STEPHEN DDirectorOct 01Sale39.531,00039,53032,603Oct 01 04:44 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOJul 11Option Exercise32.1511,700376,155122,087Jul 12 01:19 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOJul 11Sale32.3011,700377,933110,387Jul 12 01:19 PM
FOSTER JAMES CChairman, President and CEOJul 09Option Exercise32.15117,3803,773,767498,275Jul 10 04:42 PM
FOSTER JAMES CChairman, President and CEOJul 09Sale32.992,08368,722380,895Jul 10 04:48 PM
FOSTER JAMES CChairman, President and CEOJul 09Sale32.7615,186497,450382,978Jul 10 04:46 PM
FOSTER JAMES CChairman, President and CEOJul 09Sale32.6325,715839,045398,164Jul 10 04:44 PM
FOSTER JAMES CChairman, President and CEOJul 09Sale32.4574,3962,414,473423,879Jul 10 04:42 PM
JOHST DAVID PCorp Executive VPJul 06Option Exercise32.1520,290652,324158,382Jul 09 05:07 PM
JOHST DAVID PCorp Executive VPJul 06Sale33.5020,290679,715138,092Jul 09 05:07 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOJul 03Option Exercise32.1511,500369,725133,387Jul 05 11:23 AM
ACKERMAN THOMAS FCorp. Executive VP & CFOJul 03Sale34.0011,500391,000121,887Jul 05 11:23 AM
MASSARO GEORGEDirectorJun 22Sale32.881,14037,48022,148Jun 25 02:18 PM
ACKERMAN THOMAS FCorp. Executive VP & CFOJun 21Option Exercise32.152006,430122,087Jun 22 11:12 AM
ACKERMAN THOMAS FCorp. Executive VP & CFOJun 21Sale34.002006,800121,887Jun 22 11:12 AM
open in yahoo | open in reuters | open in google